跳至主要内容
临床试验/NCT03768180
NCT03768180已完成不适用

INfecTive ENdocarditis After Transcatheter Aortic Valve Replacement (TAVR) a National SwEdish Study (INTENSE)

Region Skane1 个研究点 分布在 1 个国家目标入组 4,600 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Region Skane
入组人数
4,600
试验地点
1
主要终点
Infective Endocarditis

研究概览

简要总结

This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation

详细描述

Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI) implantations in Sweden in 2008 all procedures have been added to a national database, which now contains 4500+ procedures. At the same time, all admissions to the hospital is also recorded with diagnosis in a separate database. We intend to make a nation-wide complete follow up of all TAVR/TAVI patients in swede that has received the diagnosis of infective endocarditis after the implantation. In addition data will also be collected from the national endocarditis database for detailed information of the cases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients that has under TAVR/TAVI in Sweden between 2008 and 2018

排除标准

  • Patients unable to follow up due to emigration or missing social security number

结局指标

主要结局

Infective Endocarditis

时间窗: 5 year

Patients that have suffered an infective endocarditis will be described, where survival is one important variable

次要结局

未报告次要终点

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验